March 24, 2014

Rheonix Invited to Present at ‘The Future of In-Vitro Diagnostics’ Conference hosted by Siemens

ITHACA, N.Y. – March 24, 2014 - Rheonix, Inc., a developer of fully automated molecular testing solutions, announced today that it has been invited to exhibit at “The Future of In-Vitro Diagnostics.” The exclusive conference, held April 10, 2014 in Menlo Park/Palo Alto, CA, is hosted by Siemens Venture Capital, the investment arm of Siemens, and Siemens Healthcare. The fifth annual conference brings together over 100 CEOs and CTOs, investors, key… Read More »